Atıf İçin Kopyala
Onal B., Ozen D., Demir B., GEZEN AK D., DURSUN E., Demir C., ...Daha Fazla
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, cilt.21, sa.8, ss.710-719, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
21
Sayı:
8
-
Basım Tarihi:
2020
-
Doi Numarası:
10.2174/1389201020666191105154619
-
Dergi Adı:
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, BIOSIS, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.710-719
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Background and Objective: Coronary bypass operations are commonly performed for the treatment of ischemic heart diseases. Coronary artery bypass surgery with autologous human saphenous vein maintains its importance as a commonly used therapy for advanced atherosclerosis. Vascular inflammation-related intimal hyperplasia and atherosclerotic progress have major roles in the pathogenesis of saphenous vein graft disease.